PAPER
Synthesis of Cytotoxic Thiosulfonates and Deuterated Thiosulfonates
3637
1H NMR (400 MHz, CDCl3): d = 7.57 (d, J = 8.0 Hz, 1 H), 7.22 (s,
1 H), 7.12 (d, J = 8.0 Hz, 1 H), 3.20 (s, 3 H), 2.57 (s, 3 H), 2.39 (s,
3 H).
13C NMR (100 MHz, CDCl3): d = 143.8, 143.0, 137.6, 132.4, 128.2,
123.8, 47.5, 21.4, 21.3.
MS (ESI): m/z (%) = 239 [M + Na]+ (100).
HRMS (ESI): m/z [M + Na]+ calcd for C9H12NaO2S2: 239.0171;
dissolved in dimethyl sulfoxide. The optical densities
(OD) at 570 nm were measured using a microplate reader.
The results are summarized in Figure 1. Although the cy-
totoxicities are moderate, this is the first report that thio-
sulfonates are cytotoxic. The biochemistry research using
these deuterated compounds will be reported in due
course.
found: 239.0174.
In conclusion, a new method for the synthesis of thiosul-
fonates has been developed that is operationally simple
and the yields are moderate. This reaction makes it possi-
ble to incorporate the SCD3 group of dimethyl sulfoxide-
d6 into the thiosulfonate with excellent labeling purity.
This represents the first synthesis of deuterated thiosul-
fonates. The cytotoxicity of the thiosulfonate is reported
for the first time. Improving the cytotoxicity of these com-
pounds is underway.
S-2,5-Dimethylphenyl Methanesulfonothioate (2e)
IR (KBr): 2923, 1490, 1451, 1410, 1312, 1135, 946, 814, 745 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.52 (s, 1 H), 7.28 (m, 2 H), 3.21
(s, 3 H), 2.56 (s, 3 H), 2.38 (s, 3 H).
13C NMR (100 MHz, CDCl3): d = 140.7, 138.0, 137.2, 133.1, 131.4,
126.8, 47.7, 20.9, 20.7.
MS (ESI): m/z (%) = 216 [M]+ (100).
HRMS (ESI): m/z [M + Na]+ calcd for C9H12NaO2S2: 239.0171;
found: 239.0167.
All chemicals were obtained from commercial sources or prepared
according to standard methods. 1H (400 MHz) and 13C NMR (100
MHz) were recorded on a Bruker AM-400 spectrometer relative to
TMS (1H) or CDCl3 (13C). IR spectra were recorded on BIO-RAD
FTS 3000 spectrophotometer. MS (ESI) were obtained on a Finni-
gan LCQ Advantage MAX spectrometer. HRMS (ESI) were ob-
tained on Bruker micrOTOF-QII. All new compounds were fully
characterized, known compounds (Table 1, 2a,12 2h13) were charac-
terized and the data compared to the literature.
S-2,4,6-Trimethylphenyl Methanesulfonothioate (2f)
IR (KBr): 2927, 1464, 1378, 1310, 1131, 952, 862, 744 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.06 (s, 2 H), 3.21 (s, 3 H), 2.59
(s, 6 H), 2.33 (s, 3 H).
13C NMR (100 MHz, CDCl3): d = 144.7, 142.4, 130.0, 123.5, 48.8,
22.3, 21.3.
MS (ESI): m/z (%) = 230 [M]+ (100).
HRMS (ESI): m/z [M + Na]+ calcd for C10H14NaO2S2: 253.0327;
found: 253.0327.
S-4-Isopropylphenyl Methanesulfonothioate (2b); Typical Pro-
cedure
4-Isopropylthiophenol (200 mg, 1.31 mmol) was added to a soln of
TCT (604 mg, 3.27 mmol) in anhyd DMSO (2.5 mL). The mixture
was stirred at 80 °C and until completion (13 h, TLC monitoring).
Then, the mixture was extracted with CH2Cl2 (3 × 15 mL). The sol-
vent was concentrated in vacuo to give crude product, which was
further purified by column chromatography (silica gel, petroleum
ether–EtOAc, 12:1) to afford 2b (167 mg, 55%).
S-4-Methoxyphenyl Methanesulfonothioate (2g)
IR (KBr): 2924, 1589, 1494, 1318, 1254, 1131, 1021, 953, 835
cm–1.
1H NMR (400 MHz, CDCl3): d = 7.64 (d, J = 8.8 Hz, 2 H), 7.00 (d,
J = 8.8 Hz, 2 H), 3.88 (s, 3 H), 3.18 (s, 3 H).
13C NMR (100 MHz, CDCl3): d = 162.5, 138.1, 118.5, 115.5, 55.6,
46.9.
In the reaction of TCT-activated DMSO-d6, DMSO-d6 was used to
replace DMSO.
IR (KBr): 2964, 1482, 1463, 1320, 1132, 948, 834, 740 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.64 (d, J = 8.0 Hz, 2 H), 7.36 (d,
J = 8.0 Hz, 2 H), 3.20 (s, 3 H), 3.02-2.95 (m, 1 H), 1.29 (d, J = 6.8
Hz, 6 H).
13C NMR (100 MHz, CDCl3): d = 153.1, 136.3, 128.1, 124.7, 47.3,
34.1, 23.7.
MS (ESI): m/z (%) = 219 [M + H]+ (100).
HRMS (ESI): m/z [M + Na]+ calcd for C8H10NaO3S2: 240.9964;
found: 240.9972.
S-4-Bromophenyl Methanesulfonothioate (2i)
IR (KBr): 2925, 1472, 1389, 1314, 1135, 1064, 1005, 950, 828, 741
cm–1.
1H NMR (400 MHz, CDCl3): d = 7.62 (dd, J = 8.0 Hz, 4 H), 3.22 (s,
MS (ESI): m/z (%) = 231 [M + H]+ (100).
HRMS (ESI): m/z [M + Na]+ calcd for C10H14NaO2S2: 253.0327;
3 H).
13C NMR (100 MHz, CDCl3): d = 137.6, 133.2, 127.0, 126.9, 47.7.
MS (ESI): m/z (%) = 267 [M + H]+ (100).
HRMS (ESI): m/z [M + Na]+ calcd for C7H7BrNaO2S2: 290.8941;
found: 253.0330.
S-4-Methylphenyl Methanesulfonothioate (2c)
IR (KBr): 2928, 1591, 1486, 1400, 1309, 1133, 946, 817, 740 cm–1.
found: 290.8940.
1H NMR (400 MHz, CDCl3): d = 7.61 (d, J = 8.0 Hz, 2 H), 7.31 (d,
J = 8.0 Hz, 2 H), 3.19 (s, 3 H), 2.44 (s, 3 H).
13C NMR (100 MHz, CDCl3): d = 142.5, 136.2, 130.8, 124.5, 47.2,
21.5.
Methyl 4-[(Methylsulfanyl)sulfonyl]benzoate (3)
IR (KBr): 2923, 1716, 1432, 1396, 1280, 1110, 759 cm–1.
1H NMR (400 MHz, CDCl3): d = 8.01 (d, J = 8.4 Hz, 2 H), 7.59 (d,
J = 8.4 Hz, 2 H), 3.93 (s, 3 H), 2.47 (s, 3 H).
MS (ESI): m/z (%) = 203 [M + H]+ (100).
13C NMR (100 MHz, CDCl3): d = 166.6, 143.3, 130.1, 128.1, 125.6,
52.1, 22.8.
HRMS (ESI): m/z [M + Na]+ calcd for C8H10NaO2S2: 225.014;
found: 225.0015.
MS (ESI): m/z (%) = 246 [M]+ (100).
S-2,4-Dimethylphenyl Methanesulfonothioate (2d)
IR (KBr): 2926, 1476, 1375, 1313, 1311, 945, 821, 740 cm–1.
Synthesis 2011, No. 22, 3635–3638 © Thieme Stuttgart · New York